compound tirzepatide no longer available FDA Allows Compounded During Shortage Review Compounded versions of tirzepatide (Mounjaro,
Description
180 mcg
Mechanistically, GLP-1R signaling spans Gs-cAMP/PKA, -arrestin-dependent pathways, and additional routes (including Gq contexts), aligning with anti-inflammatory, natriuretic, and antifibrotic effects observed preclinically and clinically
BRI can be displayed in a visual format
Conclusions GLP-1RA therapy in patients with CS and associated metabolic disorders led to significant improvements in weight, BMI, and glycemic control without worsening cortisol dynamics or liver function
